explore -WSS

explore

author：focus 2025-09-02 17:34:40 - browse：94493

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： How Vertex's cystic fibrosis drug is changing patients' lives

knowledge

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Why are Kaiser Permanente staff considering a strike?

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

CommonSpirit Health keeps growing, even as it loses money

Men with early prostate cancer can safely opt out of treatment

hotspot

explore

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medical student insurance fails on mental health care coverage

Hepatitis C has a cure — but many Americans still lack access to it

How a key Senate committee is planning to regulate PBMs

Bright Health sells Medicare Advantage business to Molina

How to protect coverage of PrEP

In Memoriam: Notable people who died in 2023

EpiPen alternative approval delay highlights citizen petition issue

Sports medicine is finally prioritizing gender equality

Novartis develops a rapidly manufactured CAR

focus

Second xenotransplant done with gene

How Vertex's cystic fibrosis drug is changing patients' lives

Transgender women dream of pregnancy via uterus transplants

The response to Covid

Changes to biosimilar regulatory framework must prioritize patients

Thermo Fisher plant for manufacturing gene therapies to expand

leisure time

knowledge

leisure time

focus